Reporter
-
February 8, 2021
Vanderbilt Tullahoma-Harton Hospital awarded Chest Pain Center Accreditation by the American College of Cardiology
The American College of Cardiology (ACC) has recognized Vanderbilt Tullahoma-Harton Hospital for its demonstrated expertise and commitment in treating patients with chest pain. -
February 8, 2021
Key factors in HIV-1 replication
HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication. -
February 5, 2021
Convalescent plasma improved survival in COVID-19 patients with blood cancers
Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19). -
February 4, 2021
New clue to postural tachycardia
Insight into the pathophysiology of an enigmatic and debilitating disease suggests new treatment approaches. -
February 4, 2021
Process ensures follow-up of incidental radiology findings
When people go to an emergency room after being injured, suspicious images may show up on their imaging scans that are unrelated to their injuries but may be indicative of cancer. A team at Vanderbilt University Medical Center recently established a better process for ensuring these patients receive follow-up diagnostic care, an initiative that is already receiving national recognition. -
February 4, 2021
Device offers less invasive option to treat emphysema
Life with emphysema, a lung condition that causes shortness of breath, can be miserable. People with advanced emphysema, a form of chronic obstructive pulmonary disease (COPD), are so short of breath they may need supplemental oxygen just to walk from room to room. They often have trouble with everyday tasks like bathing or cooking a meal. -
February 4, 2021
Potential biomarker for IBD severity, cancer risk identified
A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.